Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116335054 | 11633505 | 4 | F | 201507 | 20160805 | 20151015 | 20160810 | EXP | US-009507513-1510USA006561 | MERCK | 49.00 | YR | M | Y | 81.40000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116335054 | 11633505 | 1 | PS | EMEND | APREPITANT | 1 | Intravenous (not otherwise specified) | 150 MG, QD | 9600 | MG | 22023 | 150 | MG | INJECTION | QD | ||||
| 116335054 | 11633505 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 75 MG/M2, QD | U | 0 | 75 | MG/M**2 | QD | ||||||
| 116335054 | 11633505 | 3 | SS | PEMETREXED DISODIUM | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 500 MG/M2, QD | U | 0 | 500 | MG/M**2 | QD | ||||||
| 116335054 | 11633505 | 4 | C | CLONIDINE. | CLONIDINE | 1 | UNK | U | 0 | ||||||||||
| 116335054 | 11633505 | 5 | C | LORAZEPAM. | LORAZEPAM | 1 | UNK | U | 0 | ||||||||||
| 116335054 | 11633505 | 6 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | UNK | U | 0 | ||||||||||
| 116335054 | 11633505 | 7 | C | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 116335054 | 11633505 | 8 | C | THIAMINE HYDROCHLORIDE. | THIAMINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 116335054 | 11633505 | 9 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | UNK | U | 0 | INJECTION | |||||||||
| 116335054 | 11633505 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | U | 0 | ||||||||||
| 116335054 | 11633505 | 11 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | ||||||||||
| 116335054 | 11633505 | 12 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 116335054 | 11633505 | 13 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116335054 | 11633505 | 1 | Prophylaxis of nausea and vomiting |
| 116335054 | 11633505 | 2 | Non-small cell lung cancer |
| 116335054 | 11633505 | 3 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116335054 | 11633505 | OT |
| 116335054 | 11633505 | HO |
| 116335054 | 11633505 | DE |
| 116335054 | 11633505 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116335054 | 11633505 | Anaemia | |
| 116335054 | 11633505 | Dyspnoea | |
| 116335054 | 11633505 | Febrile neutropenia | |
| 116335054 | 11633505 | Neutropenia | |
| 116335054 | 11633505 | Pulmonary embolism | |
| 116335054 | 11633505 | Pulmonary toxicity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116335054 | 11633505 | 1 | 20150506 | 20150708 | 0 | |
| 116335054 | 11633505 | 2 | 20150506 | 0 | ||
| 116335054 | 11633505 | 3 | 20150506 | 0 | ||
| 116335054 | 11633505 | 4 | 20150610 | 0 | ||
| 116335054 | 11633505 | 11 | 20150414 | 0 | ||
| 116335054 | 11633505 | 12 | 20150407 | 0 | ||
| 116335054 | 11633505 | 13 | 20150605 | 0 |